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Abstract. Lipoprotein lipase (LPL) and glycolipid- 
anchored cAMP-binding ectoprotein (Gcel) are 
modified by glycosyl-phosphatidylinositol (GPI) in rat 
adipocytes, however, the linkage is potentially unsta- 
ble. Incubation of the cells with either insulin (0.1-30 
nM) or the sulfonylurea, glimepiride (0.5-20/zM), in 
the presence of glucose led to conversion of up to 35 
and 20%, respectively, of the total amphiphilic LPL 
and Gcel to their hydrophilic versions. Inositol-phos- 
phate was retained in the residual protein-linked an- 
chor structure. This suggests cleavage of the GPI an- 
chors by an endogenous GPI-specific insulin- and 
glimepiride-inducible phospholipase (GPI-PL). De- 
spite cleavage, hydrophilic LPL and Creel remained 
membrane associated and were released only if a com- 
petitor, e.g., inositol-(cyclic)monophosphate, had been 
added. Other constituents of the GPI anchor (glucos- 
amine and mannose) were less efficient. This suggests 
peripheral interaction of lipolytically cleaved LPL and 
Gcel with the adipocyte cell surface involving the ter- 
minal inositol-(cyclic)monophosphate epitope and pre- 
sumably a receptor of the adipocyte plasma mem- 
brane. In rat adipocytes which were resistant toward 
glucose transport stimulation by insulin, the sensitivity 
and responsiveness of GPI-PL to stimulation by insu- 
lin was drastically reduced. In contrast, activation of 
both GPI-PL and glucose transport by the sul- 
fonylurea, glimepiride, was not affected significantly. 
Inhibition of glucose transport or incubation of rat 
adipocytes in glucose-free medium completely abol- 
ished stimulation of GPI-PL by either insulin or 
glimepiride. The activation was partially restored by 
the addition of glucose or nonmetabolizable 2-deoxy- 
glucose. These data suggest that increased glucose 
transport stimulates a GPI-PL in rat adipocytes. 
reat body of information exists regarding the struc- 
tural diversity as well as the biosynthesis and post- 
translational attachment of glycosyl-phosphatidyl- 
inositol (GPI) ~ structures (for recent reviews see Low, 
1989; McConville et al., 1993). However, the functional 
significance of membrane anchorage via GPI structures 
versus transmembrane polypeptide domains is still a matter 
of debate. The accessibility ofGPI molecules to cleavage by 
phospholipase [(G)PI-PL] opens the possibility of a regu- 
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1. Abbreviations used in this paper: CRD, cross-reacting determinant; Gcel, 
glycolipid-anchored cAMP-binding ectoprotein; GLUT4, glucose trans- 
porter isoform 4; (G)PI-PL(C/D), (glycosyl)-phosphatidylinositol-specific 
pbospholipase (C/D); GPI, glycosyl-phosphatidylinositol; GPI-protein, 
proteins which have been synthesized with a GPI membrane anchor ir- 
respective ofwhether this moiety is preserved or cleaved; LDM, low den- 
sity microsomes; LPL, lipoprotein lipase; TX-114, Triton X-114; VSG, 
variant surface glycoprotein. 
lated release of the polypeptide portion of proteins which 
have been synthesized with a GPI membrane anchor (GPI- 
proteins) from the cell surface (for a review see Low and Sal- 
tiel, 1988; Cross, 1990). Experimental evidence has been 
presented that the released protein may exhibit altered func- 
tional characteristics (e.g., Miiller and Bandlow, 1994) and/ 
or, in the case of multicellular organisms, ay fulfill a spe- 
cial physiological role at its new location (e.g., Smith and 
Pownall, 1984). 
Whereas the number of studies on constitutive membrane 
release of GPI-proteins i steadily increasing (e.g., Almqvist 
and Carlsson, 1988; Furley et al., 1990; Hortsch and Good- 
man, 1990), only limited experimental evidence isavailable 
for regulated release so far. In a rat hepatocyte c ll line it has 
been demonstrated that the linkage between the protein moi- 
ety of heparin sulfate proteoglycan and its GPI anchor is 
cleaved by an insulin-activated PLC (Ishihara et al., 1987). 
Short-term incubation of 3T3-L1 adipocytes and BC3HI 
myocytes with insulin or fetal serum causes release of some 
GPI-anchored ectoproteins. Among the proteins liberated 
from the cell surface into the culture medium are lipoprotein 
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lipase (LPL) (Spooner et al., 1979; Chan et al., 1988), alka- 
line phosphatase (Romero et al., 1988), and a set of addi- 
tional unidentified GPI-proteins (Li anti et al., 1989). In the 
case of LPL, retention of radiolabeled myo-inositol in the 
released molecules uggested lipolytic cleavage of the GPI 
moiety in response to insulin (Chan et al., 1988). Further- 
more, treatment of isolated rat diaphragm with insulin leads 
to a decreased plasma membrane-associated 5'-nucleotidase 
activity which has been interpreted as an insulin-induced re- 
lease of the GPI-modified isoform of this enzyme from the 
plasma membrane (Klip et al., 1988). These observations 
have been interpreted in terms of a mechanistic coupling and 
direct signaling between the insulin (growth factor) recep- 
tors and GPI-PUs in mammalian cells. Finally, it has been 
demonstrated recently that glimepiride, a novel sulfonylurea 
drug (Geisen, 1988) which stimulates glucose transport in 
insulin-sensitive isolated and cultured cells (Miiller and 
Wied, 1993), induces lipolytic cleavage of the GPI anchors 
of LPL, 5'-nucleotidase and a cAMP-binding ectoprotein 
(Gcel), in cultured 3T3 adipocytes in a concentration- 
dependent manner (Mtiller et al., 1993). In parallel to these 
observations with vertebrate c lls, it has been described with 
lower eukaryotes that a nutritional upshift of spheroplasts 
from the yeast Saccharomyces revisiae from lactate to glu- 
cose medium activates a GPI-PLC which cleaves the GPI 
anchor of a cAMP-binding ectoprotein dependent on the 
concentration f glucose (MiUler and Bandlow, 1993). These 
data suggest the existence of similar signaling cascades for 
the activation of GPI-PLs in lower eukaryotes and mam- 
malian cells with multiple entry sites for hormonal, drug- 
induced, or nutritional signals. 
In an attempt to elucidate the molecular mechanism which 
links these various ignals to the lipolytic cleavage of certain 
GPI-proteins, we first studied whether isolated rat adipo- 
cytes, which are characterized by exquisite sensitivity and 
responsiveness toward hormones (like insulin), certain 
drugs (like sulfonylureas), and the nutritional situation, can 
be used as a model system for regulated GPI-protein release. 
We found that he GPI anchors of two GPI-proteins, LPL and 
the cAMP-binding ectoprotein, Gcel, are cleaved by a 
GPI-PL after stimulation of glucose transport by insulin and 
glimepiride which seems to funnel a signaling cascade lead- 
ing to activation of the GPI-PL. 
Materials and Methods 
Materials 
Affinity-purified 12SI-labeled anti-rabbit IgG from sheep and AMPLIFY 
were obtained from Amersham-Buchler (Braunschweig, Germany); re- 
agents for cell culture were obtained from GIBCO BRL (Eggenstein-Leo- 
poldshafen, Germany); protein A-Sepharose CL-4B was purchased from 
LKB/Pharmacia (Freiburg, Germany); 2-deoxyglucose, cytochalasin B, 
phloretin, and polymyxin B were bought from Sigma (Deisenhofen, Ger- 
many); protease inhibitors were bought from Boehringer Mannheim GmbH 
(Mannheim, Germany); partially purified PI-PLC (Bacillus thuringiensis) 
was delivered by Biotrend (K61n, Germany); recombinant human insulin 
and glimepiride (HOE 490) were prepared by the synthesis depa_mnent of 
Hoechst AG (Frankfurt a.M., Germany); male Wistar rats were bred and 
delivered by Hoechst AG (Tierzucht Kastengrund, Germany); affinity-puri- 
fied polyclonal nti-glucose transporter isoform 4(GLUT4) antibodies were 
obtained from rabbits injected with a peptide corresponding to the COOH- 
terminal 16 amino acids of rat GLUT4 and coupled to keyhole limpet hemo- 
cyanin; all other adiochemicals, chemicals, and antibodies were obtained 
as described previously (Miiller et al., 1993; MOiler and Wied, 1993). 
Primary Culture of Adipocytes 
Freshly prepared adipocytes were washed twice by flotation with 10 vol of 
I-IBSS (Marshall et al., 1991) containing 25 U/ml penicillin and 50 t~g/ml 
streptomycin. After the final wash, 1 ml of suspension (2 × 105 cells/ml) 
was added to 3 rnl of HBSS containing 5 mM glucose (control) or 25 mM 
glucose, 10 nM insulin, 16 mM glutamine (for desensitization f the glu- 
cose transport system) and incubated (20 h, 37°C) in sterile 50-ml polysty- 
rene tubes as described (Traxinger and Marshall, 1989). After incubation, 
control and desensitized a ipocytes were washed by flotation, twice with 
40 ml of HBSS containing 0.5% BSA and two times with 4 ml of DMEM 
containing 0.5 mM glucose, 1% BSA, 2% fetal calf serum, and 25 mM 
Hepes (pH 7.4). Then the cells were suspended at0.5 × 105 cells/ml in the 
same medium and incubated (30 rain, 37°C, gentle stirring) to allow deacti- 
vation of the glucose transport system of insulin-stimulated cells to near 
basal values before subsequent i cubation with glimepiride or insulin. Con- 
troi and desensitized a ipocytes were d rived from the same pool f com- 
monly isolated and washed cells, subjected to an equal number of washes 
so that any losses of cells were identical with the two cell populations. Sub- 
sequent procedures (photoafl~nity and metabolic labeling, incubation with 
glimepiride and insulin) were performed in parallel for both groups of cells. 
Incubation of Adipocytes with Insulin and Glimepiride 
Freshly isolated or primary-cultured a ipocytes were incubated (37°C) for 
various periods with the indicated concentrations of insulin and glimepiride 
in 1 ml of DME medium at 2 x 105 cells/ml in 10-ml scintillation vials 
under very gentle agitation with the cells floating on top of the medium in 
a thin cell layer. Insulin was added from a stock solution made daily by dis- 
solving 0.5 mg insulin in 150 #1 aqua bidest./150 ~tl of 0.1 N HCI and then 
supplementing 200 ttl of twofold KRH buffer lacking glucose; glimepiride 
was added from a 10 mM stock solution prepared aily by suspending 9.95 
nag glimepiride in 1.94 ml aqua bidest., subsequently 60/tl of I N NaOH 
was added and it was warmed up to 50-70°C. Following incubation, the 
cells were washed by flotation two times with 5 ml each of HBSS containing 
1 mM sodium pyruvate, 0.2 % BSA, I mM ETDA, 200/~M PMSF, 100/~M 
benzamidine, 20 #g/ml of leupeptin, pepstatin, aprotinin, and antipain and 
finally concentrated fivefold (1 x 106 cells/ml) in the same buffer lacking 
BSA for subsequent analysis of GPl-proteins and preparation of plasma 
membranes. 
Miscellaneous Procedures 
Published procedures were used for immunoblotting of GLUT4 using anti- 
bodies raised in rabbits against rat GLUT4 and ~25I-labeled anti-rabbit IgG 
from sheep (Towbin et al., 1979; MOiler and Wied, 1993); determination 
of 2-dcoxyglucose transport in rat adipocytes (Foley and Gliemann, 1981; 
M011er and Wied, 1993); isolation (Rodbell, 1964), metabolic labeling with 
myo-[U-14C]inositol (MOiler et al., 1994b), photoaflinity labeling with 
8-N3-[32p]cAMP (Pomerantz et al., 1975; MOiler and Bandlow, 1991), and 
subcellular fractionation of rat adipocytes (MOiler et al., 1994a); centrifu- 
gation of plasma membranes through a cushion of sucrose (MOiler, G., 
E.-M. Wetekam, C. Jung, and W. Bandlow, manuscript submitted for publi- 
cation); purification of Gcel by affinity chromatography on Nt-(2-amino - 
ethyl)cAMP-Sepharose (MOiler et al., 1992, 1993); immunoprecipitation 
of LPL using a polyclonal rabbit antiserum raised against human milk LPL 
and protein A-Sepharose (MOiler et al., 1993); Triton X-114 (TX-114) parti- 
tioning (Bordier, 1981); TLC analysis (MOiler tal., 1994b); protein deter- 
mination (FoPOv et al., 1975); SDS-PAGE and fluorography using AM- 
PLIFY (MOiler and Zimmermann, 1987). 
Results 
Hydrophilic Membrane-associated V rsions of 
Gcel and LPL Are Generated in Response to Insulin 
and Glimepiride 
We first examined whether incubation of isolated rat adipo- 
cytes with glucose, insulin or glimepiride, a representative 
of the sulfonylurea drugs, for which glucose transport stimu- 
lation in insulin-sensitive c lls in vitro has been amply 
ocumented (Jacobs et al., 1987; Rogers et al., 1987; Farese 
et al., 1991), causes conversion of amphiphilic LPL and 
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Figure 1. Lipolytic cleavage of the GPI anchors of LPL and Gcel 
in response toinsulin and glimepiride. Adipocytes were metaboli- 
cally labeled with myo-[14C]inositol and subsequently incubated 
with 10 #M glimepiride or 10 nM insulin for the periods indicated. 
Plasma membranes were prepared and subjected to TX-ll4 parti- 
tioning (top and bottom) or centrifugation through a sucrose cush- 
ion in the presence of 0.5 M NaC1 (middle). Gcel and LPL were 
purified by affinity-chromatography or immunoprecipitation, re- 
spectively, from the detergent (d)and aqueous (a) phases or from 
the pellet (p) and supernatant fractions (s) and then analyzed by 
SDS-PAGE and fluorography. Molecular masses indicated on the 
right margin were derived frommarker proteins run in parallel. 
Gcel into their hydrophilic forms. Adipocytes were metabol- 
ically labeled with myo-[14C]inositol, then incubated with 
insulin or glimepiride in the presence of glucose, and subse- 
quently subjected to amphiphilic/hydrophilic partitioning 
using TX-114 or to centrifugation through asucrose cushion. 
LPL was purified by immunoprecipitation with monospe- 
cific antiserum and Gcel by cAMP-affinity chromatography. 
The fluorogram of the SDS-PAGE (Fig. 1, top and bottom) 
shows that both, insulin and glimepiride, caused a time- 
dependent conversion of amphiphilic LPL and Gcel (parti- 
tioning into the detergent phase; Fig. 1, lanes 1 and 8) into 
the hydrophilic forms (partitioning into the aqueous phase; 
lanes 2-Tand 9-13). Significant amounts of hydrophilic Gcel 
and LPL were detectable already 2 and 5 min after the addi- 
tion of insulin or glimepiride, respectively (Fig. 1, lanes 3 
and 9). After 15 or 30 min, respectively, the amount of 
hydrophilic GPI-proteins reached a maximum (Fig. 1, lanes 
6 and 12) accounting for up to 35 % (Gcel) and 25 % (LPL) 
of the total amount of amphiphilic GPI-proteins in nonstimu- 
lated cells (compare with lanes 1 and 8). Thereafter, the 
amount of hydrophilic GPI-proteins declined again which 
was more obvious for insulin (lane 7) than glimepiride 
(lane 13). 
Since the hydrophilic forms of LPL and Gcel were recov- 
ered from isolated plasma membranes of insulin- and 
glimepiride-stimulated c lls we next studied the nature of 
their membrane association. Fig. 1 (middle) reveals that in- 
cubation with 0.5 M NaC1 and subsequent centrifugation 
through sucrose of plasma membranes isolated from insulin- 
and glimepiride-treated cells led to almost quantitative 
recovery of LPL and Gcel in the supernatant fraction (shown 
only for Gcel). Omission of the salt prevented the dissocia- 
tion from the membrane indicating bipolar interactions as 
found recently after incubation of rat adipocytes with bac- 
terial PI-PLC (Miiller, G., E.-M. Wetekam, C. Jung, and 
W. Bandlow, manuscript submitted for publication). The ki- 
netics and efficiency of the insulin- and glimepiride-induced 
membrane release and amphiphilic to hydrophilic onver- 
sion were very similar (Fig. 1, lanes 2-7 and 9-13, compare 
top and middle). These data indicate that short term treat- 
ment of rat adipocytes with insulin and glimepiride stimu- 
lates cleavage of the GPI membrane anchors of LPL and 
Gcel as has been described for 3T3 adipocytes, but in con- 
trast, does not cause dissociation from the membrane of the 
cleaved versions due to bipolar interactions with the cell 
surface. 
Recent experimental evidences suggest that some lipolyti- 
cally cleaved GPI-proteins are cognized by a receptor of 
hepatocyte and adipocyte plasma membranes (Ishihara et 
al., 1987; G. Miiller, unpublished observations). The PLC- 
cleaved proteins can be released from isolated membranes 
by incubation with certain sugar constituents of the GPI 
structure like inositol-(cyclic)monophosphate. Consequently, 
we studied whether this type of interaction also applied to 
the hydrophilic forms of LPL and Gcel generated in re- 
sponse to insulin or glimepiride. Adipocytes, metabolically 
labeled with myo-[14C]inositol, were incubated with 10 nM 
insulin or 10 #M glimepiride. Isolated plasma membranes 
were incubated with increasing concentrations of sugar com- 
pound and then spun through acushion of sucrose. The pellet 
fractions were subjected to TX-ll4 partitioning. The aque- 
ous phases and supernatant fractions were used for purifica- 
tion and SDS-PAGE of Gcel and LPL. The amounts of hydro- 
philic membrane-associated or soluble Gcel and LPL were 
determined by liquid scintillation counting of the corre- 
sponding excised gel regions. Fig. 2 shows that the amount 
of membrane-associated hy rophilic Gcel (a) and LPL (b) 
decreased with increasing concentrations of inositol- 
1,2-cyclic phosphate, inositol-l-monophosphate and glucos- 
amine but was not significantly affected by mannose. Simul- 
taneously, the amount of the hydrophilic forms increased in 
the supernatant fractions (data not shown). 85-90 % of the 
total hydrophilic Gcel and LPL generated in response to ei- 
ther insulin or glimepiride could be displaced as a maxi- 
mum. As expected, the ICs0 values of the sugar compounds 
were very similar for displacement of the GPI-proteins from 
insulin- and glimepiride-treated cells, inositol-l,2-cyclic 
monophosphate b ing most effective. But Gcel was gener- 
ally released with lower concentrations of the sugar com- 
pounds (ICs0 values; inositol-l,2-cyclic phosphate: 90-110 
#M; inositol-monophosphate: 200-220 #M; glucosamine: 
1.0-1.5 mM) than LPL (ICs0 values; inositol-l,2-cyclic 
phosphate 400-500 #M; inositol-monophosphate: 750-900 
#M; glucosamine: 3-5 mM). These findings uggest that he 
major fraction of both Gcel and LPL converted from the am- 
phiphilic into their hydrophilic forms in response to insulin 
and glimepiride was retained at the adipocyte cell surface via 
Mfiller et al. Signal Transduction in Rat Adipocytes 1269 
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Figure 2. Dissociation from 
the membrane of lipolytically 
cleaved LPL and Creel with 
sugar compounds. Adipoeytes 
were metabolically labeled 
with myo-p4C]inositol and 
subsequently incubated (30 
min, 37°C) with insulin (10 
nM) or glimepiride (10 ~tM). 
Plasma membranes were pre- 
pared, incubated (15 min, 
40C) in the absence or pres- 
ence of the indicated concen- 
trations of inositol-l,2-cyclic 
monophosphate (&), inositol- 
1-monophosphate (+), glu- 
cosamine (e), and mannose 
(.) and then centrifuged 
through a cushion of sucrose. 
The plasma membranes recov- 
ered in the pellet were subjected 
to TX-114 partitioning. Hydro- 
philic Creel (a) and LPL (b) 
were purified from the aque- 
ous phase by affinity purifica- 
tion or immunoprecipitation, 
respectively. All samples were 
separated by SDS-PAGE and fluorography. The excised gel regions containing membrane-associated hydrophilic LPL and Gcel were mea- 
sured for radioactivity. The amounts of radiolabeled total hydrophilic LPL or Gcel determined prior to centrifugation were as follows: 
Gcel (+ insulin), 4951 dpm; Gcel (+ glimepiride), 2031 dpm; LPL (+ insulin) 2265 dpm; LPL (+ glimepiride), 941 dpm. 
binding to similar or identical plasma membrane receptors 
which mainly recognize the erminal inositol-(cyclic)mono- 
phosphate epitope and, possibly, the glucosamine moiety of 
the residual GPI anchor structures. 
further experimental support. The failure to detect inosi- 
tol-l,2-cyclic phosphate and the appearance ofinositol after 
deamination may be due to either intrinsic phosphodiester- 
ase and phosphatase activities in the adipocyte plasma mem- 
The GPI-anchors of Gcel and LPL Are 
Cleaved by a Phospholipase in Response to Insulin 
and GUmepiride 
The retention of myo-[14C]inositol radiolabel in the hydro- 
philic and soluble versions of LPL and Gcel is compatible 
with the action of a phospholipase which is controlled by in- 
sulin and glimepiride. To confirm this and to gain a first in- 
sight into its cleavage specificity, we analyzed the cleavage 
site. Adipocytes were labeled with p4C]inositol and then 
stimulated with insulin (10 riM) or glimepiride (10/~M) for 
30 rain. Hydrophilic LPL and Gcel were purified from iso- 
lated plasma membranes and then subjected to acid hydroly- 
sis or nitrous deamination. Fig. 3 shows the TLC analysis 
and fluorography ofthe degradation products. After acid hy- 
drolysis most of the radiolabel of the GPI-proteins from 
insulin- and glimepiride-treated adipocytes was recovered as 
inositol (Fig. 3, lanes 1 and 4) excluding insulin- and 
glimepiride-induced conversion of myo-inositol into other 
sugar components. Nitrous acid deamination generated 
about equal amounts of radiolabeled inositol-phosphate nd 
inositol from both GPI-proteins after insulin as well as 
glimepiride stimulation (Fig. 3, lanes 2 and 5). The inosi- 
tol-phosphate was hydrolyzed to inositol by subsequent 
treatment with HC1 (Fig. 3, lanes 3 and 6) proving its iden- 
tity. The identification of inositol-monophosphate in the 
TLC patterns provides the first evidence for cleavage of the 
GPI anchors by an insulin- and glimepiride-activated 
GPI-PLC, but definite proof for this specificity will require 
Figure 3. TLC analysis of the 
GPI anchor of hydrophillc LPL 
and Gcel. Adipocy~s were 
metabolically labeled with 
myo-[~4C]inositol and subse- 
quently incubated (30 rain, 
37°C) with 10 nM insulin (Ins) 
or 10 ttM glimepiride (Gli). 
Plasma membranes were pre- 
pared and subjected to TX-114 
partitioning. Hydrophih'c Gcel 
and LPL were purified from 
the aqueous phase by affinity 
chromatography or immuno- 
precipitation, respectively, 
and then subjected to nitrous 
acid deamination (n.a.) or left 
untreated. The untreated and 
one half of the deaminated 
samples were hydrolyzed with 
HCI (a. h.), the other half was 
left untreated. All samples 
were analyzed by TLC and 
fluorograpby. The positions of 
radiolabeled markers, inosi- 
tol-l-monophosphate ( IP ) , 
myo-inositol (I) and phospha- 
tidylinositol (PI), run in paral- 
lel, are indicated on the right 
margin (Ma). 
The Journal of Cell Biology, Volume 126, 1994 1270 
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Figure 4. Immunoprecipita- 
tion of hydrophilic Geel with 
anti-CRD antibodies. Adi- 
poeytes were photoaffinity- 
labeled with 8-Nr[32p]cAMP 
and then incubated in the ab- 
sence or presence of 10 nM 
insulin or 10 #M glimepiride 
for the periods indicated (A) 
or in the absence or presence 
of various concentrations f 
insulin and glimepidde for 20 
min (B). The incubation was 
terminated by the addition of 
TX-114 (2% final concentra- 
tion) and phase separation. 
Hydrophilic Gcel was puri- 
fied from the aqueous phase 
by affinity chromatography. 
Subsequently, one half of the 
samples was subjected toquan- 
titative immunoprecipitation 
using antiq2RD antibodies (a), 
the other half was left (e). To- 
tal and immunoprecipitated 
samples were analyzed by SDS-PAGE and autoradiography or fluorography, respectively. The radioactivity (dpm values) contained in th  
gel region corresponding to 62kD (G-eel) was determined by a Berthold radioactivity scanner and calculated for each time point or concen- 
tration as the difference between radioactivity measured for incubation with insulin or glimepiride or without additions (basal). The values 
represent the means of six determinations using two different cell preparations (n = 12, +SD). 
brahe or to an enzymic mechanism of the putative adipoeyte 
GPI-PL which differs from that of bacterial PI-PLCs (Lewis 
et al., 1993). Furthermore, GPI-PLD activity associated 
with adipoeyte plasma membranes which may be due to an 
endogenous enzyme or originate from the serum cannot be 
excluded. The existence of a GPI-PLD in mammalian serum 
and tissues has well been documented (Cardoso de Almeida 
et al., 1988; Low and Prasad, 1988; Davitz et al., 1989; 
Hoener et al., 1990; Huang et al., 1990). 
To gain information about he physiological significance of 
the adipoeyte GPI-PL, we studied the time course and con- 
centration dependence of the stimulation of this enzyme by 
insulin and glimepiride. For this, the hydrophilic Gcel was 
purified from the aqueous phase ft r TX-114 partitioning of 
total lysates from adipocytes which had been photoaflinity 
labeled with 8-Nr[32p]cAMP and then incubated with in- 
sulin or glimepiride. To assay for the cleavage of the GPI an- 
thor, half of the hydrophilic Gcel was tested for anti-cross- 
reacting determinant (CRD) immunoreactivity by subsequent 
immunoprecipitation with anti-CRD antibodies. These anti- 
bodies exclusively recognize determinants in the (glycosyl)- 
phosphatidylinositol-specific phospholipase [(G) PI-PLC]- 
cleaved anchors and do not cross-react with protein epitopes 
(Cardoso de Almeida et al., 1988; Zamze t al., 1988). Fig. 
4 shows that there is a difference between the amounts of to- 
tal and immunoprecipitated hy rophilic [32P]cAMP-labeled 
Gcel purified from insulin- or glimepiride-stimulated an  
nonsfimulated a ipocytes. From the time course (Fig. 4 a) 
it can be seen that the amount of total hydrophilic form in- 
creased up to 45 min for insulin (upper half) and glimepiride 
stimulation (lower half), followed by a plateau for the next 
15-60 rain (not shown). However, at each time point anti- 
CRD antibodies recognized only a fraction of the total hydro- 
Table I. Generation of Hydrophilic Gcel Lacking the 
Anti-CRD Epitope in Response to Insulin or Glimepiride 
Gcel lacking anti-CRD epitope 
Incubation Time Total Amount Fraction 
rain arb. units % total 
Insulin 
Glimepiride 
1 1.86 47.8 
2 2.22 57.1 
5 4.36 56.1 
10 5.33 46.6 
20 6.79 42.1 
30 8.09 44.2 
45 10.37 51.8 
60 13.11 62.0 
1 0.67 46.2 
2 1.64 55.0 
5 2.42 50.1 
10 2.78 40.7 
20 3.95 40.8 
30 5.15 43.2 
45 7.41 54.7 
60 8.38 61.8 
The dpm values measured for total and anti-CRD immunoreactive hydrophilic 
[riP]cAMP photmtfinity-labeled Gcel were derived from Fig. 7 a. The amount 
of hydrophilic G-cel lacking anti-CRD epitope was calculated as the difference 
between hydrophilic total and anti-CRD immunoreactive protein (arb. units) and 
expressed as fraction of the hydrophilic total protein at each time point (set at 
100%; Fig. 7 b). 
philic Gcel which declined after 30 min. Thus, a consid- 
erable fraction f the hydrophilic form of the GPI-protein did 
not harbor the major epitope, the terminal inositol-(cyclic)- 
monophosphate residue. Gcel protein lacking this epitope 
accumulated during the incubation resulting in a drastic in- 
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Figure 5. Lipolytic cleavage of 
LPL and Gcel in response to 
insulin and glimepiride in nor- 
mal and desensitized adipo- 
cytes. Adipocytes were incu- 
bated (20 h,37°C) in primary 
culture in the presence of 0.5 
mM glucose (normal) or 20 
mM glucose plus 16mM glu- 
tamine plus 10 nM insulin 
(desensitized). Subsequently, 
the washed cells were meta- 
bolically labeled with myo- 
[14C]inositol and then incu- 
bated (30 min, 37°C) with 
various concentrations of in- 
sulin or glimepiride. Plasma membranes were prepared and subjected toTX-114 partitioning. Hydrophilic Gcel (62 kD) and LPL (60 
kD) were purified from the aqueous phase by affinity chromatography (a) or immunoprecipitation (b), respectively. All samples were ana- 
lyzed by SDS-PAGE and fluorography. The molecular masses were derived from marker proteins run in parallel. 
crease of its total amount with time (Table I). The ratio with 
regard to total hydrophilic protein increased only at later in- 
cubation times. This time course is compatible with the ob- 
served reduction of the amount of hydrophilic myo-['4C]in - 
ositol-labeled LPL and Gcel after 15 min of stimulation by 
insulin and 30 rain by glimepiride (see Fig. 1). But, these 
data suggest that, in addition to the lipolytic cleavage, a sec- 
ond hydrolytic processing event occurs within the GPI struc- 
ture of certain GPI-proteins in consequence of an incubation 
of rat adipocytes with insulin or glimepiride and removes the 
epitope(s) recognized by the anti-CRD antiserum. From the 
concentration dependence of short erm stimulation (20 min) 
(Fig. 4 b) of the PL activity (reflected by the amount of hy- 
drophilic anti-CRD immunoreactive Gcel) and of the addi- 
tional hydrolytic activity (reflected by the difference between 
total and anti-CRD immunoreactive hydrophilic protein), we 
calculated for insulin a maximal effect at 10 nM for both ac- 
tivities and EDso values of 1.2 and 2.1 nM, respectively, 
and for glimepiride a maximal effect at 10 #M and EDs0 
values of 1.7 and 2.5 #M, respectively. Thus, the concentra- 
tions of insulin and glimepiride required for stimulation of 
the PL and the second hydrolytic activity are very similar. 
These observations are compatible with the possibility that 
the lipolytic cleavage reaction is rate limiting for the subse- 
quent hydrolytic processing but do not exclude two indepen- 
dent processing mechanisms with similar dose response 
characteristics. The effective concentrations of insulin and 
glimepiride lie in the range necessary for glucose transport 
stimulation by insulin and glimepiride in rat adipocytes 
(Muller and Wied, 1993). This correlation provides a first 
hint that glucose transport is required for activation of the 
GPI-PL. 
Impairment of Glucose Transport Interferes with 
Activation of the GPI-PL 
To gain further evidence for this conclusion we used rat 
adipocytes which exhibited an impaired responsiveness and 
sensitivity of glucose transport stimulation by insulin but not 
by glimepiride. Adipocytes were incubated with high con- 
centrations of insulin, glucose, and glutamine in primary 
culture which causes desensitization f the glucose transport 
system towards insulin but not glimepiride. This is reflected 
by a 50 % reduction of the maximal insulin-stimulated glu- 
cose transport velocity and a rightward shift of the dose- 
response curve of insulin from an EDs0 of 0.45 nM to 1.85 
nM, whereas the maximal glimepiride response and glimep- 
iride dose-response curve hardly were affected (Miiller and 
Wied, 1993). The response of the PL to insulin and glimepi- 
ride was studied in desensitized cells after metabolic labeling 
with myo-[14C]inositol. The fluorograms after the SDS- 
PAGE of LPL (Fig. 5 a) and Gcel (b), lipolytically cleaved 
under these conditions, show that the amounts of the hydro- 
philic forms recovered at each insulin concentration (upper 
halves) was considerably ower in desensitized (lanes 9-14) 
versus normal adipocytes (lanes 2-7). This resulted in a re- 
duced maximal responsiveness (15-25 % for LPL, 30-35 % 
for Gcel) and sensitivity (rightward shift of the correspond- 
ing dose response curves; desensitized: EDso = 7.5 nM for 
LPL, 4.7 nM for Gcel; normal: EDs0 = 2.2 nM for LPL, 
1.7 nM for Gcel) of the PL toward stimulation by insulin. In 
contrast, its maximal responsiveness and sensitivity toward 
stimulation by glimepiride (lower halves) remained largely 
unaffected (Fig. 5, lanes 9-14). The same behavior holds for 
glucose transport: he activation by insulin is reduced (data 
Table If. Inhibition of Glucose Transport in Rat Adipocytes 
Inhibitor 
Stimulation Control Cytochalasin B Phloretin Polymyxin B 
Basal 254 + 66 223 + 81 308 + 56 198 + 38 
Insulin 3891 + 431 487 + 78 571 + 102 389 + 61 
Glimepiride 1623 + 210 305 + 55 413 + 71 255 + 41 
Adipocytes were incubated (15 min, 37°C) in the absence (Control) or presence 
of 20 #M cytochalasin B, 0.3 mM phloretin, or 0.5 mg/mi polymyxin B and 
then supplemented with insulin (10 nM final concentration) or glimepiride (10 
p.M final concentration), or left untreated. After further incubation (30 win), 
1 #Ci of v-2-[3H]deoxygincose (0.1 mM final concentration) was added. The 
uptake reaction (10 rain, 25°C) was terminated by addition of cytochalasin B 
(50 #M final concentration) to all samples and rapid centrifugation f the incu- 
bation mixture through dinonylphtalate. The cells were recovered from the oil 
layer and counted for radioactivity. Each dpm value is corrected for diffusion 
into cells and entrapping in extracellular spaces of [3H]deoxygincose by sub- 
tracting the value measured for con'esponding i cubation mixtures in the presence 
of 0.1 mM L-[3H]deoxyglucose (identical specific radioactivity). The values 
represent the means of eight determinations from two different cell preparations 
each (n = 16, +SD). 
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Figure 6. Inhibition of insulin- and glimepiride-induced GLUT4 
translocation by polymyxin B. Adipocytes were incubated (20 h, 
37°C) in primary culture in the presence of 0.5 mM glucose (nor- 
real) or 20 mM glucose plus 16 mM glutamine plus 10 nM insulin 
(desensitized). Subsequently, the adipocytes were preincubated (20 
min) without (Control) or with 0.5 mg/ml polymyxin B and then 
incubated in the absence or presence of 10 nM insulin (Ins) or 10 
/~M glimepiride (Gli). Plasma membranes (PM) and low density 
microsomes (LDM) were prepared, separated by SDS-PAGE and 
analyzed for the presence of GLUT4 by immunoblotting. Theauto- 
radiogram of a typical blot is shown. Themolecular masses are de- 
rived from marker proteins run in parallel. 
not shown here; see Miiller and Wied, 1993), whereas tim- 
ulation by glimepiride isunchanged. Thus desensitization f 
the glucose transport system in rat adipocytes i accompa- 
nied by decreased activation ofa GPI-PL or, in other words, 
the activity states of the glucose transport system and the PL 
seem to correlate. Moreover, this correlation can be ex- 
tended to the translocation of GLUT4 from tubulovesicular 
structures of the trans-Golgi network (which fractionate as 
low density microsomes [LDM]) to plasma membranes. 
GLUT4 translocation represents he molecular basis for the 
increase of glucose transport by insulin or glimepiride 
(Cushman and Wardzala, 1980; Suzuki and Kono, 1980; 
James et al., 1989; Slot et al., 1991; Miiller and Wied, 1993) 
and is impaired in desensitized adipocytes toward stimula- 
tion by insulin but not glimepiride (s e below, Fig. 6). 
Next, we tested the effect of inhibitors of glucose transport 
on the activation of the GPI-PL. Table II shows that 20 #M 
cytochalasin B, 0.3 mM phloretin or 0.5 mg/ml polymyxin 
B completely inhibited the insulin- and glimepiride-stimu- 
lated glucose transport in rat adipocytes. Cytochalasin B and 
phloretin bind directly to GLUTI and GLUT4 (for a review 
see Gould and Holman, 1993), thereby interfering with the 
facilitated iffusion of glucose. Polymyxin B inhibits insulin 
stimulation of glucose transport by blocking the insulin- 
induced translocation of GLUT4 (Cormont et al., 1992). 
This was demonstrated by successive incubation of normal 
and desensitized adipocytes with polymyxin B and insulin 
and subsequent fractionation i to LDM and plasma mem- 
branes which were assayed for GLUT4 by immunoblotting. 
The autoradiogram of the blot (Fig. 6) shows that in normal 
adipocytes insulin (lanes 2) and, to a lesser degree, glimepi- 
ride (lanes 3) caused adecrease of immunoreactive GLUT4 
(43 kD) in LDM and a corresponding increase in the plasma 
membrane r flecting translocation ofGLUT4 from LDM to 
the plasma membrane. Preincubation of normal adipocytes 
with polymyxin B or desensitization f adipocytes dimin- 
ished insulin-induced GLUT4 translocation to 15-10% (Fig. 
6, lane 5, top) or 50--40% (lane 8, top), respectively. Despite 
this block in translocation, incubation with polymyxin B led 
to a significant decline of GLUT4 in LDM (Fig. 6, lane 5, 
bottom). This is in contrast to desensitized cells (lane 8, bot- 
tom) and may be caused by targeting of LDM to an 
unidentified intracellular storage compartment or by inhibi- 
tion of fusion of LDM with the plasma membrane. Similar 
observations have been reported previously by others (Cor- 
mont et al., 1992). In desensitized adipocytes glimepiride 
caused 65-70% translocation fGLUT4 to the plasma mem- 
brane (Fig. 6, lanes 9) compared to normal cells (lanes 6). 
This translocation was reduced by polymyxin B to 25-15% 
despite significant loss of GLUT4 from LDM (Fig. 6, lanes 
6 and 12). 
Amphiphilic and hydrophilic LPL and Gcel were purified 
from plasma membranes of adipocytes, which had been 
metabolically labeled with myo-[~4C]inositol and then in- 
cubated with the respective inhibitor followed by exposure 
to insulin (Fig. 7 a) or glimepiride (b). The analysis by SDS- 
PAGE and fluorography shows that cytochalasin B, phloretin 
and polymyxin B (data not shown) did not affect he distribu- 
tion between the amphiphilic and hydrophilic versions of the 
two GPI-proteins in nonstimulated control cells (Fig. 7 a, 
Figure 7. Effect of glucose transport inhibi- 
tors on the lipolytic cleavage of LPL and 
Gcel. Adipocytes were metabolically labeled 
with myo-[t4C]inositol and subsequently in- 
cubated (20 min, 37°C) in the absence or pres- 
ence of 20/zM cytochalasin B (Cyt.B), 0.3 
mM phloretin or 0.5 mg/ml polymyxin B 
(Poly.B). The incubation was continued (30 
min) without (Control) or with 10 nM insulin 
(a) or 10 #M glimepiride (b). Plasma mem- 
branes were prepared and subjected to TX- 
114 partitioning. Hydrophilic Gcel and LPL 
were purified from the aqueous (a) and deter- 
gent (d) phases by affinity purification r im- 
munoprecipitation, respectively. All samples 
were analyzed by SDS-PAGE and fluorogra- 
phy. Molecular masses were derived from 
marker proteins run in parallel. 
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Figure 8. Effect of 2-deoxyglucose n the lipolytic cleavage ofLPL 
and G-eel. Ad i~es  were metabolically labeled with myo- 
['4C]inositol, washed and then incubated (60 rain,37"C) with 5 
mM sodium pyruvate in DME medium lacking glucose. One half 
of the cells was incubated (20 rain) with 0.5 mg/ml polymyxin B, 
the other half was left untreated. Subsequently, aliquots of the ceils 
were incubated (5 min, 37"C) in the absence (Control, anes I and 
2) or presence of 2 mM glucose (lanes 3-6) or 2-deoxyglucose 
(lanes 7-10) and then supplemented with glirnepiride (10 #M final 
concentration, shown nlyfor Gce/) or insulin (10 nM final con- 
centration). After further incubation (30 mi ), plasma membranes 
were prepared and subjected to TX-114 partitioning. Gcel and LPL 
were purified and analyzed as in Fig. 7. 
lanes 1-6). In contrast, each of the three inhibitors almost 
completely blocked the activation of the PL by insulin (Fig. 
7 a, lanes 9--14, compare with lanes 7and 8) and glimepiride 
(b, lanes 1-6, compare with lanes 7and 8). These data dem- 
onstrate that stimulation of glucose transport is required for 
activation of the GPI-PL in rat adipocytes. 
Transport of Deoxyglucose into Rat Adipocytes 
Supports the Acavation of the GPI-PL 
Finally we asked the question whether metabolism of glu- 
cose is required for activation of the GPI-PL. For this, the 
amphiphilic to hydrophilic onversion of LPL and Gcel was 
monitored in adipocytes which had been metabolically a- 
beled with myo-["C]inositol in glucose-free pyruvate- 
containing medium and then incubated with glimepiride 
(Gcel) or insulin in the presence of glucose or the non- 
metabolizable glucose analogue, 2-deoxyglucose. The 
fluorography of the SDS-PAGE (Fig. 8) of the amphiphilic 
and hydrophilic GPI-proteins hows that in the absence of 
glucose (and presence of sodium pyruvate) both, insulin and 
glimepiride, failed to support lipolytic cleavage of LPL and 
Gcel (lane 2). Supplementation of glucose restored the acti- 
vation of the GPI-PL by both agents (Fig. 8, lane 4) which 
was blocked (to 10-15 % for Gcel and 25-35 % for LPL) by 
polymyxin B (lane 6). Interestingly, addition of 2-deoxyglu- 
cose instead of glucose to the washed adipocytes resulted in 
stimulation of the lipolytic leavage by both insulin and 
glimepiride to 60-75% observed for the corresponding 
values with glucose (Fig. 8, compare lanes 8 and 4). Again, 
the GPI-PL was hardly activated when polymyxin B was 
also present (Fig. 8, lane 10). These results confirm that in- 
creased glucose flux into adipocytes i  prerequisite for stim- 
ulation of the GPI-PL and furthermore suggest that glucose 
metabolism beyond the phosphorylation step is not nec- 
essary. 
Discussion 
A functional role of GPI anchorage of LPL and Gcel in 
insulin-sensitive c lls, such as isolated or cultured adipo- 
cytes, may rely on their accessibility o specific cleavage by 
an insulin-inducible GPI-PL: short term incubation of rat 
adipocytes with physiological concentrations of insulin or 
with the sulfonylurea, glimepiride, causes the lipolytic 
cleavage of their GPI anchors as revealed by the retention f 
the myo-inositol radiolabel and anti-CRD cross-reactivity. 
This suggests stimulation of a GPI-PL by insulin or glimepi- 
ride. Since action of a GPI-PLD would destroy the epitope 
recognized by anti-CRD antibodies and since phosphate is
apparently retained with the inositol after cleavage, the 
insulin-activated PL is presumably of type C. 
Lipolytic cleavage of the GPI anchor and membrane r - 
lease of LPL may be physiologically related to the dramatic 
shift of LPL activity from adipose to muscle tissue observed 
during certain utritional situations in man (for a review see 
Smith and Pownall, 1984). In contrast, he physiological role 
for the analogous lipolytic processing of Gcel remains un- 
clear so far. We were unable to detect cAMP-dependent pro- 
tein kinase A activity in solubilized plasma membranes from 
untreated and insulin- or glimepiride-treated a ipocytes 
using the typical protein kinase A substrate Kemptide 
(Miiller, G., unpublished data). This argues against partici- 
pation of anchor cleavage in promoting cAMP-dependent ki-
nase activation of the membrane-associated or released Gcel 
protein. Such an activation of a cryptic protein kinase A ac- 
tivity upon lipolytic cleavage of a lipidic membrane anchor 
has been suggested for a mitochondrial cAMP-binding pro- 
tein in yeast (Miiller and Bandlow, 1989). 
It may be of functional significance, that after incubation 
of rat adipocytes with insulin or glimepiride we observed a
time-dependent loss of inositol-phosphate from the lipolyti- 
cally cleaved GPI anchor of hydrophilic Gcel. This may be 
taken as evidence for a secondary hydrolytic processing step 
within the residual GPI structure or near the carboxyl termi- 
nus of the GPI-protein. Apparently, this reaction exceeds the 
cleavage rate of the insulin- or glimepiride-stimulated phos- 
pholipase after about 20-30 min of incubation resulting in 
a decline of the steady state concentration f ['4C]inositol- 
labeled and anti-CRD immunoreactive Gcel protein despite 
continuous constant lipolytic cleavage. Similar observations 
have been made with GPI-proteins released from 3T3 adipo- 
cytes in response to insulin and glimepiride (Miiller et al., 
1993) as well as with the corresponding Gcel protein from 
Saccharomyces cerevisiae after glucose-induced lipolytic 
cleavage of its GPI anchor. 
Loss of the inositol residue caused by a secondary process- 
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ing event at a unique site (presumably within the carboxyl 
terminus of the GPI-protein) should result in the en bloc 
removal of phosphoinositolglycan fragments from GPI 
membrane anchors which may function in insulin, sul- 
fonylurea nd nutritional signaling. Cleavage products gen- 
erated by the insulin-stimulated metabolism ofGPI anchors 
have been speculated to act as oluble mediators of certain 
insulin effects (Lamer, 1988). Experimental support for this 
possibility originated from experiments, where insulin-sen- 
sitive rat hepatocytes and adipocytes had been incubated 
with the PLC-cleaved GPI anchors isolated from the proteo- 
lytically digested GPI-proteins, human erythrocyte acetyl- 
cholinesterase (Deeg et al., 1993) and trypanosomal soluble 
variant surface glycoprotein (Misek and Saltiel, 1992). 
These phosphoinositolglycans, linked via a phosphoethanol- 
amine bridge to the carboxy-terminal amino acids ofacetyl- 
cholinesterase and variant surface glycoprotein, acted spe- 
cifically and mimicked some of the insulin actions in a 
concentration-dependent ma ner. For the second processing 
reaction to occur and/or the subsequent uptake of the result- 
ing putative signaling molecule(s) into the cell, peripheral 
membrane association of lipolytically cleaved GPI-proteins 
at the cell surface as demonstrated for rat adipocytes in the 
present study and for yeast spheroplasts previously (Mfiller 
and Bandlow, 1993) may be prerequisite. 
A participation of a GPI-PL in mediating some of the 
short erm insulin effects is further suggested by the present 
observations that (a) GPI-PL activation depends on physio- 
logical plasma insulin levels and follows a rapid onset 
(within 2-5 min) characteristic for the regulation of key en- 
zymes of glucose and lipid metabolism by insulin (b) 
GPI-PL activation by insulin is impaired in rat adipoeytes 
which had been desensitized for glucose transport stimula- 
tion by insulin. This desensitization i  vitro was accom- 
plished by incubation with high concentrations of glucose 
and insulin (Marshall et al., 1991) thus mimicking the 
hyperinsulinemic and hyperglycemic situation typical of the 
insulin resistant state in animal models of type II diabetes 
and subjects with impaired glucose tolerance. An impair- 
ment of the insulin stimulation f a GPI-PL is a candidate 
mechanism for the postreceptor defect generally found in 
insulin-resistant states (Macaulay and Larkins, 1988). A 
block in the activation of this enzyme has also been implied 
for: (a) insulin-resistant hepatocytes isolated from Strepto- 
zotocin-induced diabetic rats since the hydrolysis of free GPI 
lipids in response to insulin and the activation of glycogen 
synthesis by equivalent volumes of hydrolysis products were 
significantly reduced compared to untreated rats (Sanchez- 
Arias et al., 1992); and (b) for type II diabetic patients ince 
the insulin-mimetic bioactivity and chiro-inositol content of 
a phosphoinositolglycan fraction isolated from equivalent 
volumes/amounts of hemodialysate, urine and muscle ho- 
mogenate were markedly reduced compared to those from 
nondiabetic ontrols (Asplin et al., 1993). 
The following lines of evidence strongly suggest that in- 
creased glucose transport mediates the stimulatory effects of 
insulin and glimepiride on the GPI-PL in rat adipocytes: (a) 
cells which have been desensitized for insulin stimulation f 
glucose transport, showed impaired insulin stimulation f
the GPI-PL with comparable elevations of the EDs0 values 
for both processes. (b) The sulfonylurea glimepiride stimu- 
lated glucose transport and GPI-PL activity in desensitized 
and normal adipoeytes toabout he same extent and within 
the same range of drug concentration (to 25-30% of the 
maximal insulin response in normal cells). (c) Inhibition of 
the stimulation of glucose transport was accompanied byan 
almost complete block of activation of the GPI-PL by insulin 
and glimepiride. Increased glucose transport is based on 
GLUT4 translocation and leads to elevated glucose flux and 
metabolism in the cell. The present data allow to dis- 
criminate between these possibilities for the functional role 
of glucose transport for activation of the GPI-PL. Glucose- 
free incubation medium does not interfere with GLUT4 
translocation but did not support insulin and glimepiride 
stimulation arguing against a direct coupling of GLUT4 
translocation to GPI-PL activation. 3-O-methylglucose 
could not replace D-glucose (G.M., unpublished observa- 
tions) thus excluding the possibility hat glucose flux across 
GLUT4 per se triggers the activation. In contrast, 2-deoxy- 
glucose did substitute for D-glucose. Thus phosphorylation 
of glucose is necessary and sufficient for activation of the 
GPI-PL. The latter data are compatible with previous 
findings showing that release of LPL from cultured adipo- 
cytes did not depend on energy supply (Spooner et al., 
1979). 
In conclusion, stimulation of glucose transport, which is 
the rate-limiting step for the generation of glucose-6-phos- 
phate seems to represent the common molecular mechanism 
which links the activation of a GPI-PL to the insulin, sul- 
fonylurea and glucose signaling cascades in organisms as 
divergent as adipocytes and yeast. Thus, in rat adipocytes the 
receptors for insulin (and growth factors) and sulfonylureas 
(Martz et al., 1989) may be coupled to the GPI-PL only in- 
directly via the formation of glucose-6-phosphate. This situ- 
ation is reminiscent of the regulation of gene expression of 
many glycolytic and lipogenic enzymes by insulin and glu- 
cose in hepatocytes and adipocytes. Insulin dramatically 
stimulated the transcription of the genes for fatty acid syn- 
thase and acetyl-CoA carboxylase in cultured rat adipose 
tissue and adult hepatocytes only when glucose or 2-deoxy- 
glucose were present in the culture medium. 3-O-methyl- 
glucose was ineffective (Foufelle et al., 1992; Fukuda et al., 
1992). On the basis ofthese xperiments, the existence of a 
nuclear factor has been proposed whose activity is con- 
trolled by the glucose-6-phosphate lev l in the cell and which 
binds to carbohydrate-responsive elements of these genes 
and regulates their rate of transcription (for recent reviews 
see Girard et al., 1994; Vaulont and Kahn, 1993). In anal- 
ogy, it is tempting to speculate about acytosolic factor which 
binds to glucose-6-phosphate and to the GPI-PL thereby 
regulating its activity. 
Received for publication 11 May 1994 and in revised form 6 June 1994. 
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